Loading company…
Surface Pharmaceuticals, Inc. develops prescription and over-the-counter eye drops for dry eye syndrome.
Founded in 2017 and based in San Diego, US, Surface Pharmaceuticals, Inc. develops and commercializes treatments for dry eye syndrome, including prescription and over-the-counter eye drops sold to eyecare professionals and through pharmacies. Kamran Hosseini is CEO. The company raised USD 21.00 mn in Series A funding on July 11, 2018 from Visionary Venture Fund, its second deal.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in